Silencing of CHD5 gene by promoter methylation in leukemia.
about
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomasArchitects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromesThe chromatin remodeler chd5 is necessary for proper head development during embryogenesis of Danio rerio.The Chromodomain Helicase DNA-Binding Chromatin Remodelers: Family Traits that Protect from and Promote Cancer.Significance of Inactivated Genes in Leukemia: Pathogenesis and Prognosis
P2860
Silencing of CHD5 gene by promoter methylation in leukemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Silencing of CHD5 gene by promoter methylation in leukemia.
@en
Silencing of CHD5 gene by promoter methylation in leukemia.
@nl
type
label
Silencing of CHD5 gene by promoter methylation in leukemia.
@en
Silencing of CHD5 gene by promoter methylation in leukemia.
@nl
prefLabel
Silencing of CHD5 gene by promoter methylation in leukemia.
@en
Silencing of CHD5 gene by promoter methylation in leukemia.
@nl
P2093
P2860
P1433
P1476
Silencing of CHD5 gene by promoter methylation in leukemia.
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0085172
P407
P577
2014-01-13T00:00:00Z